Paper · 8207484
Neuronal expression of glypican, a cell-surface glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan, in the adult rat nervous system.
Litwack ED and 3 others. J Neurosci, 1994. Cited by 92 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Neuronal expression of glypican, a cell-surface glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan, in the adult rat nervous system. Papers, record 8207484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8207484
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Neuronal expression of glypican, a cell-surface glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan, in the adult rat nervous system.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain | Major topic |
| Glycosylphosphatidylinositols | Major topic |
| Heparan Sulfate | Major topic |
| Neurons | Major topic |
| Proteoglycans | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Cell Membrane | |
| Heparan Sulfate Proteoglycans | |
| Humans | |
| In Situ Hybridization | |
| Molecular Sequence Data | |
| Peptide Mapping | |
| RNA, Messenger | |
| Rats |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| NS26862 | NINDS NIH HHS | United States | R01NS026862 | PubMed and NIH |
Source NIH RePORTER
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 92 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33,679,334 | Glypicans and Heparan Sulfate in Synaptic Development, Neural Plasticity, and Neurological Disorders. | Front Neural Circuits | 2021 | https://conductscience.org/library/papers/33679334 | PubMed |
| 29,344,975 | Extracellular matrix and traumatic brain injury. | J Neurosci Res | 2018 | https://conductscience.org/library/papers/29344975 | PubMed |
| 28,739,923 | Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28739923 | PubMed |
| 28,464,847 | Glycosaminoglycans are involved in bacterial adherence to lung cells. | BMC Infect Dis | 2017 | https://conductscience.org/library/papers/28464847 | PubMed |
| 26,958,642 | Data in support of the identification of neuronal and astrocyte proteins interacting with extracellularly applied oligomeric and fibrillar α-synuclein assemblies by mass spectrometry. | Data Brief | 2016 | https://conductscience.org/library/papers/26958642 | PubMed |
| 25,669,902 | Poly-arginine and arginine-rich peptides are neuroprotective in stroke models. | J Cereb Blood Flow Metab | 2015 | https://conductscience.org/library/papers/25669902 | PubMed |
| 23,911,103 | Unbiased discovery of glypican as a receptor for LRRTM4 in regulating excitatory synapse development. | Neuron | 2013 | https://conductscience.org/library/papers/23911103 | PubMed |
| 21,235,445 | Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses. | Curr Pharm Biotechnol | 2011 | https://conductscience.org/library/papers/21235445 | PubMed |
| 21,110,089 | Functions of chondroitin sulfate and heparan sulfate in the developing brain. | Neurochem Res | 2011 | https://conductscience.org/library/papers/21110089 | PubMed |
| 20,883,685 | Altering Glypican-1 levels modulates canonical Wnt signaling during trigeminal placode development. | Dev Biol | 2010 | https://conductscience.org/library/papers/20883685 | PubMed |
1 to 10 of 21
See all 21 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GENBANK | L34067 |
Source GENBANK
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8207484
GET https://conductscience.org/api/papers/v1/8207484/cited_by?page=2